Product Information
RAGWITEK SUBLINGUAL TABLET is a brand product labeled by ALK-Abello A S, priced at $11.7396 per EA under NDC 52709160103. Its NADAC has been published 129 times since Apr 17, 2024.
Strength
12 [Amb'a'1'U]/1
Manufacturer
ALK-Abello A SNDC
52709160103
Classification
Brand
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
9/23/2026
Active Ingredients
AMBROSIA ARTEMISIIFOLIA POLLENApproval Type
Biologic (BLA)
FDA Application
BLA125478On Market Since
4/17/2014
Pharmacological Classes
Price Statistics
The NADAC for RAGWITEK SUBLINGUAL TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.7396 per EA |
|---|---|
| All-time high | $11.7396 (Sep 30, 2026) |
| All-time low | $11.0542 (Aug 21, 2024) |
| 52-week high | $11.7396 |
| 52-week low | $11.3451 |
| Median price | $11.4029 |
| Average price | $11.3924 |
| Largest weekly change | +3.0% (Jan 8, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the AMBROSIA ARTEMISIIFOLIA POLLEN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ALK-Abello A S manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
AMBROSIA ARTEMISIIFOLIA POLLEN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RAGWITEK SUBLINGUAL TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RAGWITEK SUBLINGUAL TABLET, manufactured by ALK-Abello A S, is $11.7396 per EA (NDC 52709160103), effective Sep 30, 2026.
How has the price of RAGWITEK SUBLINGUAL TABLET changed over time?
Over the history we have for it, the NADAC for RAGWITEK SUBLINGUAL TABLET has risen 6.1%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for RAGWITEK SUBLINGUAL TABLET?
Since Apr 17, 2024, the NADAC for RAGWITEK SUBLINGUAL TABLET has ranged from a low of $11.0542 (Aug 21, 2024) to a high of $11.7396 (Sep 30, 2026), with a median of $11.4029 per EA.
Are there cheaper alternatives to RAGWITEK SUBLINGUAL TABLET?
No other NADAC-published product currently shares the active ingredient and strength of RAGWITEK SUBLINGUAL TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RAGWITEK SUBLINGUAL TABLET?
RAGWITEK SUBLINGUAL TABLET (NDC 52709160103) is labeled by ALK-Abello A S, and CMS classifies it as a brand product.